Skip to main content
Articles & Publications , Dr. Andy Lewis

Video Interview: Dr. Andrew Lewis Discusses CMC Challenges for GLP-1 and Oral Peptides with PharmTech Europe

PharmTech.com and Pharmaceutical Technology Europe logos

In this video interview with PharmTech Europe, Dr. Andrew Lewis, Chief Scientific Officer at Quotient Sciences, discussed the CMC challenges with GLP-1 and oral peptides during his attendance at CPHI Milan.   

Watch the recent video with PharmTech Europe and Andy Lewis
Watch a recent video with PharmTech Europe and Andy Lewis.

Dr. Lewis talked about the chemistry, manufacturing, and control (CMC) challenges encountered during the development of glucagon-like peptide 1 (GLP-1) and oral peptides. 

Watch the full video and read the article on PharmTech Europe.

 

Get in touch
Humanity can't afford to wait, so neither can we.